This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Good morning everyone. Thanks for joining us. Our next session here in this room is from Bruker. I am very pleased to have Bill Knight, the CFO and currently the Interim COO as well join us to give us an overview and then from here we will have our breakout down in the Cedona room.
Thank you. Good morning everyone. Also here from Bruker is Stacey Desrochers who is our Corporate Treasurer and Investment Relations Officer. The standard Safe Harbor statement. Bruker is in its 52
nd year, is a company which was founded in 1960. It was a private company for 40 some years, founded by Günther Laukien. The Laukien family still has a significant ownership interest in the company of 48.5%. Frank Laukien and his brother Jörg still have significant management roles. Frank is our CEO.
The company historically had a very strong science-focused leading-edge, sometimes bleeding-edge, but over the years has been able to establish some dominant positions because of that focus on science and technology and solutions. In the past probably seven eight years having gone public, there is much more of an operational focus as well on products and product solutions on market, market growth, market shares, operational improvements, balance sheet management.
So the company I think today is really poised for continued outstanding topline growth. We've got a much broader market mix of products from life science, material science, food, feed, environmentals, defense than what we have had in the past. It is a very much a global company. The company was founded in Germany. So we do have our most significant production and product development operations are in Germany with production facilities in France and Switzerland as well.